Mary-Ann Etiebet, MD has joined the Merck for Mothers team as our new Executive Director. Dr. Etiebet is a physician, researcher and strong advocate for women's health. She joins Merck from Premier Inc, where she was a Principal in the Population Health Management team and led efforts to support Greater New York Hospital Association (GNYHA) members in the successful implementation of the New York State Medicaid Delivery System Reform and Incentive Payment (DSRIP) program through learning networks, improvement collaboratives and innovation pilots. Previously, she served as the Director of Ambulatory Care Strategies for New York City Health and Hospitals where she managed large-scale primary care integration and population health initiatives, and as the Senior Clinical Technical Advisor for the University of Maryland School of Medicine HIV/AIDS Care and Treatment Program in Nigeria, where she developed programming that resulted in significant improvements in healthcare access, delivery and outcomes.
Dr. Etiebet has extensive experience working with international development partners to design, manage and evaluate programs that address the needs of vulnerable and at risk populations. She has successfully built broad-based and multi-stakeholder constituencies to advance healthcare transformation in diverse settings, including the private, public and non-profit sectors. In her new Merck for Mothers role, she will be responsible for successfully implementing a robust set of innovative programs across the globe; designing new high-impact partnerships; managing relationships with important external stakeholders (government ministries, policy makers, private and government donors, global/maternal health experts, implementing partners); and serve as an internal and external ambassador of the initiative.
Dr. Etiebet's strong record of success, as well as her experience in public-private partnerships, population health and global health program development, make her particularly well suited for this role. Dr. Etiebet earned her MD and MBA from Yale University. She completed her residency and fellowship training at the New York-Presbyterian Hospital System, and is Board Certified in Infectious Disease.